- Cell Adhesion Molecules Research
- Cardiomyopathy and Myosin Studies
- S100 Proteins and Annexins
- Neuroscience and Neuropharmacology Research
- COVID-19 and healthcare impacts
- Radiopharmaceutical Chemistry and Applications
- Renal Transplantation Outcomes and Treatments
- Pediatric Urology and Nephrology Studies
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Lanthanide and Transition Metal Complexes
- Organ Transplantation Techniques and Outcomes
- Healthcare cost, quality, practices
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Infection Control and Ventilation
- Parathyroid Disorders and Treatments
- Organ Donation and Transplantation
- Epilepsy research and treatment
Inserm
2019-2021
Assistance Publique – Hôpitaux de Paris
2019-2021
Laboratoire de Recherche Vasculaire Translationnelle
2019-2021
Hôpital Bichat-Claude-Bernard
2021
Université Paris Cité
2019
Université de Bordeaux
2015
Institut de Neurosciences Cognitives et Intégratives d’Aquitaine
2015
Centre National de la Recherche Scientifique
2015
Abstract There is a need for new targets to specifically localize inflammatory foci, usable in wide range of organs. Here, we hypothesized that the cleaved molecular form CD31 suitable target imaging inflammation. We evaluated bioconjugate D-P8RI, synthetic peptide binds all cells with CD31, an experimental rat model sterile acute Male Wistar rats were injected turpentine oil into gastrocnemius muscle two days before 99m Tc-HYNIC-D-P8RI (or its analogue L-Proline) SPECT/CT or [ 18 F]FDG...
<sup>123</sup>I-iodobenzovesamicol is a SPECT radioligand selective for the vesicular acetylcholine transporter (VAChT) and used to assess integrity of cholinergic pathways in various neurologic disorders. The current noninvasive method quantitative analysis <sup>123</sup>I-iodobenzovesamicol, based on multilinear reference tissue model 2 (MRTM2), requires repeated scans several hours, limiting its application clinical trials. Our objective was validate simplified acquisition single static...
The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between infection exposure risk for patient (and staff) and associated with delaying or cancelling nuclear medicine examination. This study aimed at quantifying impact of first COVID-19 lockdown in France on examination volume together cancellation non-attendance.We retrospectively assessed planned examinations from 1 month before to after French high-volume departments (NMD)...